Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.

about

Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum.

P2860

Q40130432-B2C4E79F-B9CE-476E-8ACB-807E7982AE99 Q49193526-A83C2A8D-47E4-495F-AA79-EEDFE9DF218A

P2860

Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.

Item

http://www.wikidata.org/entity/Q41695565

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.

@en

type

Item

label

Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.

@en

prefLabel

Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.

@en

P1476

Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.

@en

P2093

Andreas H Diacon

http://www.w3.org/2001/XMLSchema#string

Lize van der Merwe

http://www.w3.org/2001/XMLSchema#string

Sven O Friedrich

http://www.w3.org/2001/XMLSchema#string

Xavier A Kayigire

http://www.w3.org/2001/XMLSchema#string

P2860

Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective

Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis

Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy

Origins and evolution of antibiotic resistance

The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.

The association between sterilizing activity and drug distribution into tuberculosis lesions.

Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence

Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis.

Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes.

Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients.

P31

scholarly article

P356

10.1128/AAC.02220-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28167550

http://www.w3.org/2001/XMLSchema#string

P932

5365665

http://www.w3.org/2001/XMLSchema#string

Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.

about

P2860

P2860

Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932